History of tonsillectomy and risk of oropharyngeal cancer.

Base of the tongue cancer Head and neck cancer Oropharyngeal cancer Tonsil Tonsillar cancer Tonsillectomy

Journal

Oral oncology
ISSN: 1879-0593
Titre abrégé: Oral Oncol
Pays: England
ID NLM: 9709118

Informations de publication

Date de publication:
06 2021
Historique:
received: 22 10 2020
revised: 06 04 2021
accepted: 08 04 2021
pubmed: 28 4 2021
medline: 1 2 2022
entrez: 27 4 2021
Statut: ppublish

Résumé

To investigate whether palatine tonsillectomy in youth influences the risk of oropharyngeal cancers (OPC) by assessing the association between history of tonsillectomy and risk of tonsillar, base of tongue (BOT) cancer, and other head and neck cancers (HNC). RACKAM was a case-case study comparing frequency of tonsillectomy history in individuals diagnosed with HNC from 2013 to 2018 in 15 centers across France. History of tonsillectomy was defined using combined assessment of patients' recollections and surgeons' visualizations of tonsil area. OPC subsite-specific odds ratios (OR) of tonsillectomy were calculated using multinomial logistic regression with non-oropharyngeal HNC as reference. 1045 patients were included in the study. Frequency of tonsillectomy was 19.5% in patients with tonsillar cancer (N = 85), 49.3% in BOT (N = 76), 33.8% in other oropharyngeal cancers (N = 202) and 38.0% in non-oropharyngeal HNC (N = 682). History of tonsillectomy was inversely associated with tonsillar cancer (adjusted OR 0.4; 95% CI 0.2-0.8), and positively associated with BOT cancer (adjusted OR 1.8; 95% CI 1.1-3.1), but was not associated with all OPC combined (adjusted OR 1.1; 95% CI 0.8-1.4). Sensitivity analyses considering only patients' or surgeons' assessments of tonsillectomy provided comparable results. We confirm the long-term protective effect of tonsillectomy performed in youth on future risk of tonsillar cancer, and our study is the second to report a concurrent increased risk of BOT cancer. Our data suggest that tonsillectomy in youth shifts the site of the first diagnosed oropharyngeal tumor and has a limited impact on overall risk of OPC.

Identifiants

pubmed: 33905915
pii: S1368-8375(21)00125-1
doi: 10.1016/j.oraloncology.2021.105302
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

105302

Informations de copyright

Copyright © 2021. Published by Elsevier Ltd.

Auteurs

Jean-Damien Combes (JD)

Early Detection, Prevention and Infections Branch, International Agency for Research on Cancer (IARC/WHO), 69372 Lyon Cedex 08, France. Electronic address: CombesJD@iarc.fr.

Nicolas Voisin (N)

Early Detection, Prevention and Infections Branch, International Agency for Research on Cancer (IARC/WHO), 69372 Lyon Cedex 08, France; Department of Otolaryngology-Head and Neck Surgery, Croix Rousse Hospital, Service d'ORL et chirurgie cervico-faciale, Hospices Civils de Lyon (Hospital Group of Lyon), 69004 Lyon, France. Electronic address: nicolas.voisin@chu-lyon.fr.

Sophie Périé (S)

Department of Otolaryngology Head Neck Surgery, Faculty of Medicine Sorbonne University, Tenon Hospital, Assistance Publique Hôpitaux Paris (APHP), Paris, France; Department of Otolaryngology Head and Neck Surgery, COM CCF Maillot, Hartmann Clinic, 92200 Neuilly sur Seine, France.

Olivier Malard (O)

Department of Otorhinolaryngology and Head and Neck Surgery, Nantes University Hospital, 44036 Nantes, France. Electronic address: olivier.malard@chu-nantes.fr.

Franck Jegoux (F)

Department of Otorhinolaryngology and Head and Neck Surgery, Rennes University Hospital, 35000 Rennes, France. Electronic address: Franck.Jegoux@chu-rennes.fr.

Ritoungarte Nadjingar (R)

ENT and Head & Neck Surgery Department, Beauvais Hospital, 60000 Beauvais, France. Electronic address: r.nadjingar@ch-beauvais.fr.

Guillaume Buiret (G)

Department of Ear, Nose, and Throat, Valence Hospital, 26000 Valence, France. Electronic address: gbuiret@ch-valence.fr.

Pierre Philouze (P)

Department of Otolaryngology-Head and Neck Surgery, Croix Rousse Hospital, Service d'ORL et chirurgie cervico-faciale, Hospices Civils de Lyon (Hospital Group of Lyon), 69004 Lyon, France. Electronic address: pierre.philouze@chu-lyon.fr.

Renaud Garrel (R)

Department of Otorhinolaryngology and Head and Neck Surgery, University Hospital of Montpellier, 34000 Montpellier, France. Electronic address: r-garrel@chu-montpellier.fr.

Sébastien Vergez (S)

Head and Neck Surgery Department, Toulouse University Hospital Center, University Cancer Institute of Toulouse Oncopôle, 31000 Toulouse, France. Electronic address: vergez.s@chu-toulouse.fr.

Nicolas Fakhry (N)

Department of Otorhinolaryngology, Head and Neck Surgery, University Hospital Center la Conception, Assistance Publique - Hôpitaux de Marseille, Aix Marseille University, Marseille, France. Electronic address: Nicolas.Fakhry@ap-hm.fr.

Christian Righini (C)

Department of Otolaryngology-Head and Neck Surgery, Grenoble University Hospital, 38000 Grenoble, France. Electronic address: CRighini@chu-grenoble.fr.

Haitham Mirghani (H)

Department of Head and Neck Oncology, Gustave Roussy Cancer Campus, 94800 Villejuif, France. Electronic address: Haitham.Mirghani@gustaveroussy.fr.

Justine Lerat (J)

Department of ENT Surgery, Limoges University Hospital, 87000 Limoges, France. Electronic address: Justine.Lerat@chu-limoges.fr.

Nicolas Saroul (N)

Head and Neck Surgery Department, Clermont-Ferrand University Hospital, 63000 Clermont-Ferrand, France. Electronic address: nsaroul@chu-clermontferrand.fr.

Benjamin Verillaud (B)

Department of Otolaryngology Head Neck Surgery, Lariboisière Hospital, Assistance Publique Hôpitaux Paris (APHP), Inserm U1141, Paris University, Paris, France.

Emmanuel Bartaire (E)

Department of Otorhinolaryngology and Head and Neck Surgery, Faculté Libre de Médecine de Lille, GHICL Saint-Vincent-de-Paul Hospital, 59000 Lille, France. Electronic address: Bartaire.Emmanuel@ghicl.net.

Philippe Céruse (P)

Department of Otolaryngology-Head and Neck Surgery, Croix Rousse Hospital, Service d'ORL et chirurgie cervico-faciale, Hospices Civils de Lyon (Hospital Group of Lyon), 69004 Lyon, France. Electronic address: philippe.ceruse@chu-lyon.fr.

Gary M Clifford (GM)

Early Detection, Prevention and Infections Branch, International Agency for Research on Cancer (IARC/WHO), 69372 Lyon Cedex 08, France. Electronic address: cliffordg@iarc.fr.

Silvia Franceschi (S)

Centro di Riferimento Oncologico (CRO), IRCCS, 33081 Aviano, PN, Italy. Electronic address: silvia.franceschi@cro.it.

Jean Lacau St Guily (J)

Department of Otolaryngology Head Neck Surgery, Faculty of Medicine Sorbonne University, Tenon Hospital, Assistance Publique Hôpitaux Paris (APHP), Paris, France; Department of Otolaryngology Head Neck Surgery, Rothschild Foundation, 75019 Paris, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH